Journal of Diabetes Investigation

Scope & Guideline

Exploring the frontiers of diabetes and metabolism.

Introduction

Immerse yourself in the scholarly insights of Journal of Diabetes Investigation with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2040-1116
PublisherWILEY
Support Open AccessYes
CountryAustralia
TypeJournal
Convergefrom 2010 to 2024
AbbreviationJ DIABETES INVEST / J. Diabetes Investig.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The Journal of Diabetes Investigation aims to provide a comprehensive platform for the dissemination of research and insights related to diabetes and its complications. The journal focuses on various aspects of diabetes research, including clinical, epidemiological, and translational studies, with an emphasis on understanding the pathophysiology, treatment, and management of diabetes.
  1. Clinical Diabetes Research:
    The journal publishes studies focused on clinical aspects of diabetes, including treatment efficacy, management strategies, and patient outcomes.
  2. Diabetes Pathophysiology:
    Research exploring the underlying mechanisms of diabetes, including metabolic dysfunction, insulin resistance, and genetic factors.
  3. Diabetes Complications:
    Studies addressing the complications associated with diabetes, such as cardiovascular disease, neuropathy, and kidney disease.
  4. Epidemiology and Public Health:
    Research examining the epidemiological trends, risk factors, and public health implications of diabetes on a global scale.
  5. Innovative Therapies and Technologies:
    The journal includes research on new therapeutic approaches, including pharmacological treatments, lifestyle interventions, and technological advancements in diabetes care.
  6. Nutritional and Lifestyle Factors:
    Papers addressing the role of diet, exercise, and lifestyle modifications in the prevention and management of diabetes.
  7. Patient-Centered Care and Quality of Life:
    Research focusing on the psychosocial aspects of diabetes, including patient-reported outcomes and quality of life.
The Journal of Diabetes Investigation has identified several emerging themes that reflect the current trends in diabetes research. These areas are gaining traction as researchers explore new dimensions of diabetes management and care.
  1. Digital Health and Technology:
    There is a growing emphasis on the use of digital health technologies, including remote monitoring and telemedicine, to enhance diabetes management and patient engagement.
  2. Personalized Medicine Approaches:
    Emerging research focuses on personalized treatment strategies tailored to individual patient profiles, including genetic, metabolic, and lifestyle factors.
  3. Impact of Gut Microbiota on Diabetes:
    Studies examining the relationship between gut microbiota composition and diabetes risk or management are trending, highlighting the importance of the microbiome in metabolic health.
  4. Psychosocial Factors in Diabetes Management:
    An increased focus on the psychological and social determinants of health in diabetes care, including mental health, stigma, and patient support systems.
  5. Sustainability in Diabetes Care:
    Research exploring sustainable practices in diabetes care, including nutrition, exercise, and community-based interventions, is gaining attention.
  6. Longitudinal and Real-World Evidence Studies:
    There is a trend towards conducting longitudinal and real-world studies that provide insights into diabetes management in diverse populations and settings.

Declining or Waning

While the Journal of Diabetes Investigation continues to thrive in many areas, certain themes have shown a decline in prominence over recent years. These waning scopes may reflect shifts in research priorities or emerging interests in the field.
  1. Traditional Pharmacological Approaches:
    There has been a noticeable decline in studies focusing solely on traditional pharmacological treatments, as researchers increasingly explore combination therapies and innovative drugs.
  2. Basic Science Without Clinical Relevance:
    Research that focuses solely on basic science without clear clinical applications is becoming less common, as there is a growing demand for studies that directly impact patient care.
  3. Generic Diabetes Education Programs:
    The prevalence of studies solely focused on generic diabetes education programs has diminished, with a shift towards more tailored and culturally relevant educational interventions.
  4. Longitudinal Studies with Limited Generalizability:
    Long-term studies that lack diverse populations or fail to address generalizability are less frequently published, as there is a push for more representative research.
  5. Single-Factor Analyses:
    Research focusing on single factors affecting diabetes management, such as one dietary component or one medication, is waning in favor of multifactorial approaches that consider the complexity of diabetes.

Similar Journals

Diabetologie

Advancing diabetes research for a healthier future.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7447Frequency: 8 issues/year

Diabetologie is a dedicated academic journal published by Springer Heidelberg, focusing on the diverse fields of endocrinology, diabetes, and metabolism. With the ISSN 2731-7447 and E-ISSN 2731-7455, this journal serves as a significant platform for the dissemination of innovative research and evidence-based practices within the rapidly evolving landscape of diabetes care and management. Although currently not classified as Open Access, the journal provides robust subscription options that grant access to a wealth of peer-reviewed articles, making it an invaluable resource for researchers and practitioners alike. With an H-index that reflects its emerging influence and a Scopus ranking in the 10th percentile within its category, Diabetologie aims to elevate the scientific understanding of diabetes through rigorous scholarship. The journal captures the latest findings and clinical advancements from 2022 to 2024, placing a particular emphasis on novel therapeutic strategies and technological innovations. By fostering a collaborative environment dedicated to the improvement of diabetes outcomes, Diabetologie stands as a crucial contributor to the global dialogue on diabetes treatment and research.

Diabetes Mellitus

Fostering collaboration in the fight against diabetes.
Publisher: ENDOCRINOLOGY RESEARCH CENTREISSN: 2072-0351Frequency: 4 issues/year

Diabetes Mellitus, published by the Endocrinology Research Centre in the Russian Federation, is an esteemed open-access journal dedicated to the field of endocrinology, diabetes, and metabolism. Since its inception in 1998, this journal has been a pivotal platform for disseminating cutting-edge research and comprehensive reviews that address the multifaceted challenges posed by diabetes. With its current quartile ranking of Q4 in Endocrinology and the associated fields, as well as commendable involvement in the broader scope of Internal Medicine, Diabetes Mellitus plays a crucial role in enhancing clinical practices and informing innovative therapeutic strategies. The journal caters to a diverse audience of researchers, healthcare professionals, and students, particularly those seeking to expand their knowledge and improve patient outcomes in diabetes care. With a commitment to fostering scientific conversation and collaboration, Diabetes Mellitus is an invaluable resource for anyone engaged in the fight against diabetes and its complications.

CURRENT DIABETES REVIEWS

Unveiling the Latest in Diabetes Research
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3998Frequency: 9 issues/year

CURRENT DIABETES REVIEWS is a leading academic journal published by Bentham Science Publishers Ltd, dedicated to disseminating high-quality reviews and cutting-edge insights in the field of Endocrinology, Diabetes and Metabolism. Established in 1996 and actively publishing from 2005 to 2024, this journal holds a prestigious position within the academic community, evidenced by its Q2 ranking in both relevant categories for 2023 and its impactful presence in Scopus, where it ranks #83 out of 244 in Endocrinology and Diabetes and Metabolism. Despite being a subscription-based journal, it provides researchers, healthcare professionals, and students with valuable contributions that significantly advance the understanding of diabetes and related metabolic disorders. With a commitment to promoting interdisciplinary collaboration and innovation, CURRENT DIABETES REVIEWS serves as an essential resource for those seeking to stay abreast of the latest developments in diabetes research and therapies.

Diabetes & Metabolism Journal

Transforming diabetes research into actionable insights.
Publisher: KOREAN DIABETES ASSOCISSN: 2233-6079Frequency: 6 issues/year

Diabetes & Metabolism Journal, published by the Korean Diabetes Association, is a leading open-access journal dedicated to advancing the field of endocrinology, with a specific focus on diabetes and metabolism. Since its establishment in 1991, the journal has provided a robust platform for disseminating high-quality research, contributing significantly to our understanding of diabetes pathophysiology, treatment, and prevention strategies. The journal boasts an impressive impact factor, ranking in the top quartile (Q1) of its category and occupying the 28th position out of 244 in Scopus rankings, which places it in the 88th percentile among its peers. With its commitment to open access, researchers, professionals, and students globally can explore the latest findings and innovative solutions in diabetes research. The journal continues to serve as an essential resource for those dedicated to improving patient outcomes and advancing scientific knowledge in the metabolic disorders domain.

Current Diabetes Reports

Fostering collaboration in the global diabetes community.
Publisher: CURRENT MEDICINE GROUPISSN: 1534-4827Frequency: 12 issues/year

Current Diabetes Reports is a leading academic journal published by CURRENT MEDICINE GROUP, dedicated to advancing research and clinical practices in the field of diabetes and endocrinology. With an impressive impact factor and ranked in the prestigious Q1 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 2001 and converging years up to 2024, Current Diabetes Reports aims to disseminate high-quality, peer-reviewed research articles, reviews, and clinical studies that address the multifaceted challenges of diabetes management and treatment. As it continues to thrive within a robust international community, the journal provides critical insights that are essential for improving patient outcomes and informing public health policies in the United States and beyond.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo

Fostering excellence in endocrine research and clinical practice.
Publisher: SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDMISSN: 1646-3439Frequency: 2 issues/year

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

Diabetology International

Empowering researchers to shape the future of diabetes.
Publisher: SPRINGER JAPAN KKISSN: 2190-1678Frequency: 4 issues/year

Diabetology International, published by Springer Japan KK, is a leading journal dedicated to the field of diabetes research. With an ISSN of 2190-1678 and E-ISSN of 2190-1686, this journal plays a pivotal role in disseminating innovative studies and findings that advance understanding in endocrinology, diabetes, and metabolism. Its rigorous peer-review process ensures the publication of high-quality research articles, review papers, and clinical studies, making it a valuable resource for researchers, healthcare professionals, and students. The journal is indexed in Scopus and maintains respectable rankings in its categories, standing at Q3 in Endocrinology, Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. Furthermore, the journal facilitates collaborations and promotes the exchange of ideas from its base in Tokyo, Japan, helping to bridge the gap between academia and clinical practice. As it converges through the years from 2010 to 2024, Diabetology International remains committed to addressing the evolving challenges in diabetes care and research, supporting the global community's pursuit of knowledge in this crucial field.

Journal of Diabetes Research

Fostering collaboration for better diabetes outcomes.
Publisher: HINDAWI LTDISSN: 2314-6745Frequency:

Journal of Diabetes Research, published by HINDAWI LTD, is a leading open-access journal dedicated to advancing the understanding and management of diabetes. Established in 2013, the journal has swiftly gained recognition, achieving a commendable Q2 ranking in both the categories of Endocrinology and Diabetes and Metabolism, as well as in Biochemistry, Genetics and Molecular Biology. With an impressive Scopus ranking of #42 out of 244 in its field, the journal provides a platform for cutting-edge research that addresses the multifaceted challenges posed by diabetes. Offering unrestricted access to its articles since its inception, the journal aims to foster collaboration and exchange of innovative ideas among researchers, clinicians, and students worldwide. It is particularly vital for those engaged in diabetes research, as it publishes influential studies that impact clinical practices and enhance patient outcomes. For academics and professionals seeking to contribute to the growing body of knowledge in diabetes, the Journal of Diabetes Research serves as a valuable resource.

Journal of Diabetes

Fostering collaboration for better diabetes outcomes.
Publisher: WILEYISSN: 1753-0393Frequency: 12 issues/year

The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.

Clinical Obesity

Empowering Change Through Evidence-Based Insights
Publisher: WILEYISSN: 1758-8103Frequency: 6 issues/year

Clinical Obesity, published by WILEY, is a leading journal in the field of Endocrinology, Diabetes, and Metabolism that strives to advance the understanding of obesity-related health issues. With an ISSN of 1758-8103 and an E-ISSN of 1758-8111, this journal provides a platform for cutting-edge research and findings pertaining to the epidemiology, pathophysiology, prevention, and treatment of obesity. Recognized with a Q2 ranking in both Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous) categories, and boasting a Scopus rank of #90 out of 244, Clinical Obesity encompasses innovative studies that influence clinical practice and public health policies. While this journal operates under a subscription model, its discipline-specific contributions are invaluable for researchers, healthcare professionals, and students keen on addressing the complexities of obesity in a comprehensive manner.